Then, MINT was compared to sixteen sequential approaches and was shown to be the fastest and most accurate method to discriminate and predict three human cell types (human Fibroblasts, human Embryonic Stem Cells and human induced Pluripotent Stem Cells) and four subtypes of breast cancer (Basal, HER2, Luminal A and Luminal B). Here, ERBB2 is linked to breast cancer.